C223 (Alendronate Sodium 35 mg)
Pill with imprint C223 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Cipla USA Inc..
Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C223
Alendronate Sodium
- Imprint
- C223
- Strength
- 35 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0223
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
sodium starch glycolate type A potato,
corn starch,
magnesium stearate
Note: Inactive ingredients may vary.
Related Images for "C223"
More about alendronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 114 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Alendronate (Advanced Reading)
- Alendronate Effervescent Tablets
- Alendronate Tablets
- Alendronate Oral Solution
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.